Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells

scientific article

Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/IAI.01218-07
P932PMC publication ID2258801
P698PubMed publication ID18160480
P5875ResearchGate publication ID5689913

P50authorMartha TorresQ77437183
Claudia CarranzaQ88769013
P2093author name stringRogelio Hernandez-Pando
Bruno Rivas-Santiago
Eduardo Sada
Diana Aguilar-Leon
Juan Leon Contreras
Esmeralda Juarez
P2860cites workInteraction of pathogenic mycobacteria with the host immune systemQ22252359
Human CAP18: a novel antimicrobial lipopolysaccharide-binding proteinQ24682905
Epithelial antimicrobial peptides in host defense against infectionQ24791605
Antimicrobial peptides of multicellular organismsQ28131811
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring ProjectQ28145755
LL-37, the only human member of the cathelicidin family of antimicrobial peptidesQ28241675
The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infectionQ28244066
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial responseQ28298985
Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosisQ28346140
Regulation of cathelicidin gene expression: induction by lipopolysaccharide, interleukin-6, retinoic acid, and Salmonella enterica serovar typhimurium infection.Q33591272
Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophilsQ33695688
Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft modelQ33849677
Human {beta}-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cellsQ33946746
Correlates of protective immunity to Mycobacterium tuberculosis in humansQ33956267
Innate antimicrobial peptide protects the skin from invasive bacterial infectionQ34102960
Host antimicrobial defence peptides in human diseaseQ34557523
Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibioticQ34694936
Cathelicidins and Innate Defense Against Invasive Bacterial InfectionQ35585098
Toll-like receptor pathways in the immune responses to mycobacteriaQ35862734
Neutrophil-mediated innate immune resistance to mycobacteriaQ35865371
Update in tuberculosis 2005.Q36403165
Tuberculosis: back on the immunologists' agendaQ36450881
Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replicationQ36602184
Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contactsQ37144577
Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88.Q37700302
Microbial DNA induces a host defense reaction of human respiratory epithelial cellsQ38339218
The efficiency of the translocation of Mycobacterium tuberculosis across a bilayer of epithelial and endothelial cells as a model of the alveolar wall is a consequence of transport within mononuclear phagocytes and invasion of alveolar epithelial ceQ39653495
Endogenous antimicrobial peptides and skin infections in atopic dermatitisQ40698186
The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responsesQ40702297
Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: essential role of IL-1 from infected monocytes in a NF-kappa B-dependent network.Q40928245
Interleukin-18 expression by alveolar epithelial cells type II in tuberculosis and sarcoidosisQ42489556
Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogensQ43646136
Antimicrobial peptides in the innate immunity of infectious diseasesQ44129327
Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuliQ46961436
Expression of human beta defensin (HBD-1 and HBD-2) mRNA in nasal epithelia of adult cystic fibrosis patients, healthy individuals, and individuals with acute cold.Q51727354
Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study.Q55036173
Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulatorQ57940216
Primary type II alveolar epithelial cells present microbial antigens to antigen-specific CD4+ T cellsQ62734176
Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosisQ71764410
Innate immunity to Mycobacterium tuberculosisQ73805385
[Neutrophil participation in early control and immune activation during experimental pulmonary tuberculosis]Q79191668
beta-Defensin gene expression during the course of experimental tuberculosis infectionQ80082567
[Cell immunity response in human pulmonary tuberculosis. Review]Q81625412
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectMycobacterium tuberculosisQ130971
P304page(s)935-941
P577publication date2007-12-26
P1433published inInfection and ImmunityQ6029193
P1476titleExpression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells
P478volume76